0001225208-17-016427.txt : 20171020 0001225208-17-016427.hdr.sgml : 20171020 20171020101428 ACCESSION NUMBER: 0001225208-17-016427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171018 FILED AS OF DATE: 20171020 DATE AS OF CHANGE: 20171020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lupisella Frank Jr CENTRAL INDEX KEY: 0001361680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 171146175 MAIL ADDRESS: STREET 1: C R BARD INC 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2017-10-18 0000009892 BARD C R INC /NJ/ BCR 0001361680 Lupisella Frank Jr C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Vice President and Controller Common Stock 2017-10-18 4 M 0 5710.0000 97.6850 A 15879.0488 D Common Stock 2017-10-18 4 M 0 3463.0000 84.5750 A 19342.0488 D Common Stock 2017-10-18 4 S 0 9173.0000 325.0002 D 10169.0488 D Common Stock 1100.2220 I 401(k) Plan Option (Right to Buy) 97.6850 2017-10-18 4 M 0 5710.0000 0.0000 D 2022-12-12 Common Stock 5710.0000 0.0000 D Option (Right to Buy) 84.5750 2017-10-18 4 M 0 3463.0000 0.0000 D 2021-12-14 Common Stock 3463.0000 0.0000 D Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Includes 0.0015 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017. Includes 30.361 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017. Represents the weighted average sales price for price increments ranging from $325.00 to $325.02. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 0.566 shares acquired under the Company's 401(k) Plan from February 4, 2017 to August 4, 2017. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Options fully vested and are currently exercisable. Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Myra McGinley, Attorney-in-Fact 2017-10-20